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ABSTRACT  31 
Purpose Blackcurrant contains anthocyanins that could alter cardiovascular function and reduce 32 
cardiovascular disease risk. We examined dose responses of New Zealand blackcurrant (NZBC) extract 33 
on cardiovascular function during supine rest.  34 
Methods Fifteen endurance trained male cyclists (age: 38±12 years, height: 178±5 cm, body mass: 35 
76±10 kg, V̇O2max: 56±8 mL∙kg-1∙min-1, mean±SD) were randomly assigned using a counterbalanced 36 
Latin square design to complete four conditions, a control of no NZBC, or one of three doses (300, 600 37 
or 900 mg∙day-1) of NZBC extract (CurraNZTM) for seven-days with a fourteen-day washout. 38 
Cardiovascular function (i.e. blood pressure, heart rate, ejection time, cardiac output, stroke volume 39 
and total peripheral resistance) during supine rest was examined (Portapres® Model 2).  40 
Results Systolic and diastolic blood pressure, heart rate and ejection time were unchanged by NZBC. 41 
A dose effect (P<0.05) was observed for cardiac output, stroke volume and total peripheral resistance. 42 
A trend for a dose effect was observed for mean arterial blood pressure. Cardiac output increased by 43 
0.6±0.6 L·min-1 (15%) and 1.0±1.0 L·min-1 (28%) and stroke volume by 5±8 mL (7%) and 6±17 mL 44 
(18%) between control and 600, and 900 mg∙day-1, respectively. Total peripheral resistance decreased 45 
by 4±3 mmHg·L-1·min-1 (20%) and 5±9 mmHg·L-1·min-1 (20%) for 600, and 900 mg∙day-1.  46 
Conclusion Seven-days intake of New Zealand blackcurrant extract demonstrated dose-dependent 47 
changes on some cardiovascular parameters during supine rest in endurance-trained male cyclists.  48 
 49 
Keywords: Cardiovascular function; New Zealand blackcurrant; anthocyanins; sports nutrition; 50 
polyphenols.  51 
 52 
Abbreviations:  53 
FMD  flow-mediated dilation 54 
NADPH  Nicotinamide-adenine dinucleotide phosphate 55 
NZBC  New Zealand blackcurrant 56 
V̇O2max   Maximal rate of oxygen uptake 57 
WRmax   Maximum work rate  58 
 59 
INTRODUCTION  60 
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Blackcurrant (Ribes nigrum) is a rich source of flavonoids, especially the anthocyanins delphinidin-3-61 
rutinoside, delphinidin-3-glucoside, cyanidin-3-rutinoside and cyanidin-3-glucoside (Kähkönen et al. 62 
2003). In animal studies, anthocyanins induced vasodilation and relaxation in thoracic aortic rings in 63 
male Wistar rats, and prevented loss of endothelium-dependent relaxation by exposure to exogenous 64 
reactive oxygen species in porcine arteries (Bell and Gochenaur 2006). Such observations in humans 65 
may, in the long term, reduce cardiovascular risk factors. Indeed, numerous epidemiological studies 66 
indicate that consumption of foods high in flavonoids can reduce the risk of cardiovascular disease 67 
(Huxley and Neil 2003; Mink et al. 2007).  68 
In in vitro animal studies, physiological responses have shown dose-response effects to 69 
anthocyanins. For example, blackcurrant concentrate induced dose-dependent relaxation on 70 
norepinephrine contracted rat aorta (Nakamura et al. 2002) and incubation of bovine arterial cells with 71 
cyanidin-3-glucoside increased endothelial nitric oxide synthase (eNOS) expression in a dose-72 
dependent manner (Xu et al. 2004a). However, caution is required to generalise findings from in vitro 73 
observations with anthocyanins on arteries and myocardium to in vivo human conditions due to the low 74 
bioavailability of anthocyanins and possible additional cardiovascular effects by the anthocyanin 75 
metabolites. Increases in circulating anthocyanin metabolites were linked with a dose-dependent 76 
increase in flow-mediated dilation (FMD) up to 310 mg of blueberry anthocyanins with higher doses 77 
having no further increases (Rodriguez-Mateos et al. 2013).  78 
However, studies that highlighted a dose-response effect of intake of berry anthocyanins on 79 
cardiovascular parameters were executed in healthy untrained subjects (Rodriguez-Mateos et al. 2013, 80 
2016). We observed in endurance trained athletes that a daily intake of New Zealand blackcurrant 81 
powder for seven days increased stroke volume and cardiac output by 25% and 26%, respectively, and 82 
total peripheral resistance was decreased by 16% with no changes in systolic, diastolic or mean arterial 83 
blood pressure during supine rest (Willems et al. 2015). This observation was with a daily intake of 84 
138.6 mg∙day-1 of blackcurrant anthocyanins and it is not known whether there is dose-dependent effect 85 
on cardiovascular function during supine rest. The dose-dependent cardiovascular responses to berry 86 
anthocyanin intake are unknown for those regularly undertaking endurance training, which possess 87 
already cardiovascular adaptations by the endurance training (for a review see Hellsten and Nyberg 88 
2015). It is possible that an endurance trained cardiovascular system may not clearly respond to dose 89 
effects of anthocyanin intake. We therefore hypothesized that there would be no dose-response effects 90 
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of a rich berry anthocyanin-containing extract on cardiovascular function during supine rest in trained 91 
male cyclists. The aim of the present study was to examine the dose-response effects of New Zealand 92 




Fifteen endurance trained men (age: 38±12 years, height: 178±5 cm, body mass: 76±10 kg, V̇O2max: 97 
57±8 mL∙kg-1∙min-1, WRmax: 378±55 W) provided written informed consent to participate in the study. 98 
Participants were recruited from local cycling clubs with a history of cycling participation of greater 99 
than 3 years and were not involved in a structured training programme for the study duration, but 100 
typically performed cycling exercise for 6 to 10 hours a week. All participants were non-smokers and 101 
they were taking no nutritional supplements. The study was approved by the University of Chichester 102 
Research Ethics Committee with protocols and procedures conforming to the 2013 Declaration of 103 
Helsinki. 104 
Experimental Design 105 
Participants visited the laboratory for 5 visits at the same time of day (8:00am). Before arrival, 106 
participants were instructed to abstain from vigorous exercise for 48 hours, alcohol for 24 hours and 107 
caffeine-containing products on the day of testing. Before commencing data collection on that visit, 108 
participants verbally acknowledged compliance to the experimental requirements. During the first visit, 109 
stature (Seca 213, Seca, Birmingham, UK), body mass (Kern ITB, Kern, Balingen, Germany) and body 110 
fat (Tanita BC418 Segmental Body Composition analyzer, Tanita, Illinois, USA) were measured. 111 
Subsequently, participants completed an incremental intensity maximal cycling test to volitional 112 
exhaustion for calculation of maximal oxygen uptake (V̇O2max) and maximum work rate (WRmax; the 113 
last complete work rate, plus the fraction of time spent in the final non-completed work rate multiplied 114 
by the work rate) on an electronically controlled cycle ergometer (SRM ergometer, SRM International, 115 
Jülich Germany).  116 
Participants were assigned, in a randomised, counterbalanced Latin-square design, to three NZBC 117 
doses (i.e. 1, 2 or 3 capsules a day) for seven-days and one control condition of no dose. The 300 mg 118 
active cassis capsules contained 105 mg of anthocyanins, consisting of 35-50% delphinidin-3-119 
rutinoside, 5-20% delphinidin-3-glucoside, 30-45% cyanidin-3-rutinoside, 3-10% cyanidin-3-glucoside 120 
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(CurraNZTM, Health Currancy Ltd, Surrey, UK). Participants were instructed to take the capsules, with 121 
breakfast (one capsule per day, 300 mg∙day-1 condition), 12 hours apart (two capsules per day, 600 122 
mg∙day-1 condition) and evenly spaced through the day (three capsules per day, 900 mg∙day-1 123 
condition). Optimal dosing duration of NZBC extract is not known. However, previous studies on the 124 
effectiveness of berry juice intake in humans also used multiple days of intake (Connolly et al. 2006; 125 
Howatson et al. 2010).  126 
On the final day of supplementation, participants reported to the laboratory, two hours post-prandial of 127 
a standard breakfast (i.e. one slice of buttered bread or toast ~840 kJ, ~30 g carbohydrate, ~6 g protein 128 
and ~7 g fat) and all the capsules required for that condition. Between laboratory visits, there was a 129 
fourteen-day washout period. An anthocyanin intake for one month similar to highest dose in the 130 
present study returned biochemical and biomarkers of antioxidant status to baseline of after a fifteen-131 
day washout (Alvarez-Suarez et al. 2014). The NZBC capsules were independently analysed and 132 
confirmed the ingredients present with an absence of caffeine. Participants then rested for 5 minutes in 133 
a supine position before beat-to-beat blood pressure (Portapres® Model 2, Finapres Medical Systems 134 
BV, Amsterdam, The Netherlands) was recorded for 20-minutes during supine rest (see below). 135 
Cardiovascular responses in rest are affected by posture position (Nishiyasu et al. 1998).  136 
Anthocyanin Consumption, Physical Activity and Dietary Standardization 137 
Participants completed a food frequency questionnaire that listed the amount and frequency of 138 
anthocyanin containing foods and drinks compiled from the Phenol Explorer database (Neveu et al. 139 
2010). Daily anthocyanin intake was calculated as the sum of consumption frequency of each food 140 
multiplied by the anthocyanin content for the portion size. Daily intake of anthocyanins was calculated 141 
to be 67±47 mg∙day-1. 142 
Participants were instructed to keep their weekly exercise schedule as consistent as possible. All 143 
participants recorded their dietary intake and exercise on a written diary 48 hours prior to the first 144 
experimental condition (i.e. visit 2) and were then told to replicate this for all subsequent experimental 145 
visits (i.e. visits 3, 4, 5) using the first diary as a guide, while recording on a new diary their dietary 146 
intake and exercise for that visit. Food diaries were analysed using Nutritics (Nutritics LTD, Dublin, 147 
Ireland) for carbohydrate, fat and protein intake and total energy intake (kJ).  148 
There were no differences (P>0.05) in absolute or relative per kilogram of body mass values for 149 
carbohydrate, fat, protein, or total energy for 48 hours prior to each experimental visit (Table 1). 150 
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Analysis of the food diaries identified that all participants reported 100% adherence to the dietary 151 
instructions 48 hours prior to each visit.   152 
Maximal Rate of Oxygen Uptake 153 
V̇O2max and WRmax were determined with an incremental intensity cycling test to volitional exhaustion. 154 
The test began at 50 W for 4 minutes and subsequently increased by 30 W each minute with 155 
participants instructed to keep pedal cadence between 70 and 90 rev·min-1. Expired air samples were 156 
collected using the Douglas bag technique with separate air samples collected for a minimum of 3-157 
minutes before participants reached volitional exhaustion. Expired air was analysed with a three-158 
pointed calibrated gas analyser (Series 1400, Servomex, Crowborough, UK), and volume measured 159 
(Harvward Apparatus Ltd., Edenbridge, UK). Gas volumes were calculated using Haldane 160 
transformation and standardisation to STPD conditions, with consideration of inspired fraction of 161 
oxygen and carbon dioxide measured within the laboratory during the protocol. V̇O2max and WRmax were 162 
measured in visit 1. 163 
Cardiovascular Function Measurements  164 
Cardiovascular responses were recorded using a beat-to-beat blood pressure monitoring system during 165 
20 minutes of rest in a supine position using the arterial volume clamp method (Penaz 1973). The 166 
Portapres® is a beat-to-beat finger blood pressure analyser that allows the non-invasive continuous 167 
measurement of haemodynamic parameters. The cardiac output calculated by the Portapres has shown 168 
to be significantly correlated (r=0.87, P<0.01) with cardiac output measurements by ultrasound 169 
Doppler from rest up to 130% of the ventilatory threshold during semi-supine cycling (Sugawara et al. 170 
2003). The finger cuff was positioned around the same finger of the left hand. Cardiovascular measures 171 
were averaged over 10 consecutive beats, with the lowest systolic blood pressure and associated 172 
measures recorded. Systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, 173 
heart rate, ejection time, cardiac output, stroke volume and total peripheral resistance were recorded 174 
(Beatscope 1.1a., Finapres Medical Systems BV, Amsterdam, The Netherlands).  175 
Statistical Analysis  176 
An a-priori power analysis indicated a sample size of 15 would allow a detection of a 26% increase in 177 
cardiac output with a high statistical power (1 − β = 0.95: 0.05 = α level). Statistical analyses were 178 
completed using SPSS 20.0 (SPSS, Chicago, USA). Differences between the dosing conditions (0 vs. 179 
300 vs. 600 vs. 900 mg∙day-1) were analysed with a one-way within subjects analysis of variance 180 
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(ANOVA) with between dose condition difference examined with a paired samples t-test. Mauchley’s 181 
Test of Sphericity was conducted to test for homogeneity of data and where violations were present 182 
Greenhouse-Geisser adjustments were made. To determine the effect size of responses, Cohen’s d were 183 
calculated with Cohen (1988) describing an effect size of <0.2 as trivial, 0.2-0.39 as a small, 0.4-0.69 184 
as a moderate and ≥0.7 as a large magnitude of change. Statistical significance was accepted at P<0.05. 185 




There were no differences between the dosing conditions for systolic blood pressure (P=0.35), diastolic 190 
blood pressure (P=0.60), heart rate (P=0.56) and ejection time (P=0.52) (Figures 1 a, b, c and d, 191 
respectively). There was a dose effect of NZBC on mean arterial pressure (P=0.023), cardiac output 192 
(P<0.001), stroke volume (P=0.014) and total peripheral resistance (P=0.012) (Figures 1 e, f, g and h, 193 
respectively).  194 
Mean arterial pressure (Fig. 1e) exhibited a decrease of 7±9 mmHg (8%, 11 of 15 participants 195 
decreased, d=0.76) between 0 and 600 mg·day-1 and 5±7 mmHg (6%, 14 of 15 participants decreased, 196 
d=0.69) between 300 and 900 mg·day-1 (P<0.05). There was a trend for a lower mean arterial pressure 197 
of 5±11 mmHg (6%) (P=0.1) between 0 and 900 mg·day-1 and 7±12 mmHg (7%) (P=0.05) between 198 
300 and 600 mg·day-1. NZBC increased cardiac output by 0.6±0.6 L·min-1 (15%, 14 of 15 participants 199 
increased, d=0.93), 1.0±1.0 L·min-1 (28%, 11 of 15 participants increased, d=0.94) and 0.6±0.9 L·min-1 200 
(15%, 13 of 15 participants increased, d=0.67) between 0 and 600 mg·day-1, 0 and 900 mg·day-1 and 201 
300 and 900 mg·day-1 (all P<0.05), respectively (Fig. 1f). Between 0 and 600 mg∙day-1 and 0 and 900 202 
mg∙day-1, stroke volume (Fig. 1g) increased by 5±8 mL (7%, 13 of 15 participants increased, d=0.70) 203 
and 6±17 mL (18%, 13 of 15 participants increased, d=0.95), respectively. For total peripheral 204 
resistance (Fig. 1h), a decrease of 4±3 mmHg·L-1·min-1 (20%, 13 of 15 participants decreased, d=1.29), 205 
5±9 mmHg·L-1·min-1 (20%, 13 of 15 participants decreased, d=0.60) and 3±4 mmHg·L-1·min-1 (15%, 206 
11 of 15 participants, d= 0.78) was observed between 0 and 600 mg·day-1, 0 and 900 mg·day-1 and 300 207 
and 900 mg·day-1 (P<0.05), respectively.  208 
 209 
DISCUSSION 210 
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This is the first study to examine the dose-response effects of NZBC extract on cardiovascular function 211 
during supine rest in trained male cyclists. The principle finding from the present study was that NZBC 212 
extract increased cardiac output and stroke volume, and decreased total peripheral resistance in a dose-213 
dependent manner in endurance trained male cyclists, with changes having moderate and large effect 214 
sizes. There was a trend for a dose effect for mean arterial blood pressure. 215 
Willems et al. (2015) also observed no changes in systolic or diastolic blood pressure and heart rate 216 
following seven-days intake of NZBC powder in trained male and female triathletes. However, 217 
increases in cardiac output by 25%, stroke volume by 26%, and a decrease in total peripheral resistance 218 
by 16% were observed (Willems et al. 2015). The present study observed similar group mean 219 
increases, but following a dose almost three times that of Willems et al (2015) (~139 vs ~315 mg∙day-1 220 
anthocyanin). This may have resulted from the different way in which NZBC was delivered. Willems 221 
et al (2015) used NZBC powder dissolved in water while the present study used capsulated NZBC 222 
extract which may affect absorption rate of anthocyanin and also bypasses the potentially degrading 223 
properties of saliva (Kamonpatana et al. 2012). Additionally, Willems et al (2015) observed no change 224 
in mean arterial pressure, whereas in this study differences between 0 and 600 and 900 mg∙day-1 were 225 
observed with large and moderate effect sizes, respectively. This indicates that higher intakes of 226 
anthocyanins are associated with reduced mean arterial pressure (Jennings et al. 2012).  227 
The dose-dependent cardiovascular function responses during supine rest in endurance trained 228 
individuals in the present study support those studies examining the dose-response relationships of 229 
anthocyanin on FMD in healthy untrained individuals. For example, Rodriguez-Mateos et al (2013) 230 
reported a dose-dependent increase in FMD up to 310 mg anthocyanin, and then a plateau above this 231 
dose. The present study observed no significant increases between 600 and 900 mg∙day-1 NZBC (210 232 
and 315 mg∙day-1 anthocyanin, respectively) on any cardiovascular parameter, indicating a levelling off 233 
in cardiovascular responses during supine rest with a dose of 600 mg∙day-1 NZBC extract. However, 234 
the responses above 900 mg∙day-1 NZBC extract are unknown. It is possible, however, that a plateau on 235 
cardiovascular function exists in a similar fashion to the results of the study by Rodriguez-Mateos et al 236 
(2013), as uptake of higher intakes of NZBC extract may be limited by mechanisms for anthocyanin 237 
absorption (Kurilich et al. 2005).  238 
Upon ingestion, anthocyanins have poor bioavailability (Czank et al. 2013). Their uptake is affected by 239 
gut microflora [for review see Kemperman et al. (2010)], with inter-individual variations in gene 240 
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content of gut bacterial species of 13% observed (Zhu et al. 2015). Furthermore, George et al (2012) 241 
observed that expression of the Glu298Asp single nucleotide polymorphism in the endothelial nitric 242 
oxide synthase gene differentially affects the endothelium-dependent vasodilation response to a fruit 243 
and vegetable puree drink. Taken together, such factors may explain the inter-individual variation for 244 
NZBC extract on cardiovascular function responses during supine rest. 245 
Blackcurrant anthocyanins are quickly absorbed and excreted with values reaching maximum plasma 246 
concentrations within 2 hours (Matsumoto et al. 2001). Therefore, metabolites of anthocyanins, or 247 
synergistic action of metabolites, could lead to the cardiovascular responses during supine rest. In 248 
addition, metabolites have been shown to remain within the plasma for 48 hours following intake 249 
(Czank et al. 2013). Therefore, a build-up of metabolites over the 7-day supplementation period within 250 
the present study and effects of the metabolites may have caused the altered cardiovascular function 251 
during supine rest. However, we cannot exclude that the cardiovascular responses during supine rest in 252 
the present study may have been caused by acute responses to the anthocyanin intake as measurements 253 
were taken 2 hours after intake. In both Willems et al. (2015) and the present study, the last intake 254 
across the seven days was taken 2 hours before the recording of cardiovascular function during supine 255 
rest. This is supported by observations that increases in FMD have occurred 1-2 hours following an 256 
intake of blueberry polyphenols and coincides with a peak in phenolic metabolites such as ferulic acid, 257 
isoferulic acid, vanillic acid, 2-hydroxybenzoic acid, benzoic acid and caffeic acid in the plasma 258 
(Rodriguez-Mateos et al. 2013), but anthocyanin composition of blueberries differ from blackcurrant 259 
with potential consequences for the occurrence of plasma metabolites. Similarly, Kent et al. (2016) 260 
observed that a single serving of cherry juice (~207 mg anthocyanins) reduced systolic and diastolic 261 
blood pressure and heart rate 2 hours following intake and this coincided with a peak in caffeic acid. 262 
Therefore, future studies should examine the acute responses for cardiovascular function during supine 263 
rest to NZBC extract intake with measurement of phenolic metabolites. It is possible that these 264 
phenolic metabolites maybe responsible for the possible mechanisms for the observed effect in the 265 
present study. For example, they have been observed to influence human vascular smooth muscle cell 266 
behaviour in vitro (Keane et al. 2016a) and may also increase nitric oxide availability, as shown by 267 
inhibiting NAPH oxidase (Rodriguez-Mateos et al. 2013) and increasing endothelial nitric oxide 268 
synthase expression (Xu et al. 2004b). While these effects upon expression and activity of nitric oxide 269 
would potentially result in vascular responses, Keane et al. (2016b) observed plasma nitrite and nitrate 270 
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(surrogate markers for nitric oxide production) to be unaffected by cherry anthocyanins. Therefore, the 271 
effects of anthocyanin metabolites on vascular smooth cell behaviour seems the most likely mechanism 272 
for the cardiovascular responses, which lead to a decrease in total peripheral resistance and mean 273 
arterial pressure in the present study. Whilst indirect, the decrease in total peripheral resistance also 274 
suggests an increased peripheral blood flow during supine rest as changes in arterial diameter influence 275 
blood flow (Mayet and Hughes 2003), an observation which has been previously been made following 276 
intake of blackcurrant anthocyanins (Matsumoto et al. 2005). However, the combination of decreased 277 
total peripheral resistance and mean arterial pressure with increased cardiac output and stroke volume 278 
with no change in heart rate and systolic or diastolic blood pressure suggests more complex 279 
mechanisms. For example, an elevation of mean arterial pressure can only result from an increase in 280 
cardiac output, an increase in total peripheral resistance, or both (Mayet and Hughes 2003). However, a 281 
decreased mean arterial pressure and total peripheral resistance as in this study indicates greater venous 282 
return resulting in the increased cardiac output from a larger end diastolic filling during the cardiac 283 
cycle.  284 
Limitations  285 
For the present study, various limitations should be considered. Firstly, the short time frame of the 286 
present study does not indicate benefits for longer-term consumption and cardiovascular health. 287 
Secondly, the study population consisted of healthy men who regularly participate in cycling exercise 288 
and observations cannot be extended to the general population, and further work is required to identify 289 
whether similar cardiovascular responses would occur in women, untrained populations and those with 290 
cardiovascular disease conditions. However, future work should examine the potential consequences of 291 
increased cardiac output in rest on cardiomyocyte oxygen consumption. Thirdly, the present study 292 
supplemented with capsules of NZBC extract. Therefore, these results are limited to this delivery 293 
mechanism and it is unknown if similar responses are observed from whole unprocessed blackcurrant 294 
intake. Finally, in present study, dietary intake was controlled for 48 hours before each visit, with no 295 
differences observed, but the total polyphenol intake was not measured. Therefore, we cannot exclude 296 
that the intake of dietary polyphenols including anthocyanins acted synergistically with the NZBC 297 
anthocyanin intake in the present study.  298 
Conclusion  299 
Accepted version European Journal of Applied Physiology, December 2016 
11 
 
In conclusion, New Zealand blackcurrant extract taken in capsules for seven-days increased cardiac 300 
output and stroke volume, and decreased mean arterial pressure and total peripheral resistance during 301 
supine rest in a dose-dependent manner up to a daily intake of 900 mg∙day-1 (315 mg∙day-1 anthocyanin) 302 
in endurance trained male cyclists. While anthocyanins have been shown to influence cardiovascular 303 
responses in diseased and untrained populations, these findings indicate that anthocyanins also alter 304 
cardiovascular function during supine rest in endurance trained cyclists in a dose-dependent manner. In 305 
a previous study with the lowest dose of New Zealand blackcurrant as used in the present study, we did 306 
not observe differences in cardiovascular responses between 40% and 80% of maximum power 307 
(Willem et al. 2015). Future work should examine whether higher doses of New Zealand blackcurrant 308 
affects the cardiovascular responses during exercise. 309 
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Fig. 1. a: Systolic blood pressure, b: Diastolic blood pressure, c: Heart rate, d: Ejection time, e: Mean 420 
arterial pressure, f: Cardiac output, g: Stroke volume, h: Total peripheral resistance during supine rest 421 
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following 0 or 300, 600 and 900 mg∙day-1 of New Zealand blackcurrant extract in 15 endurance trained 422 
male cyclists. Data are mean±SD. * indicates difference between doses (P<0.05), # indicates a trend 423 
between doses 424 
 425 
Table 1. Dietary intake 48 hours before each visit for each treatment condition.  426 
 
0 mg∙day-1 300 mg∙day-1 600 mg∙day-1 900 mg∙day-1 
Carbohydrate (g) 494±91 495±90 479±85 490±101 
(g·kg body mass-1) 6.7±1.8 6.7±1.7 6.5±1.6 6.6±1.9 
Fats (g) 228±68 228±68 230±65 235±73  
(g·kg body mass-1) 3.1±1.0 3.1±0.9 3.1±0.9 3.1±1.0 
Protein (g) 216±59 221±58 217±56 220±60 
(g·kg body mass-1) 2.9±0.9 3±0.9 2.9±0.8 3.0±0.9 
Total Energy Intake (kJ) 20654±2950 20804±3080 20724±2805 20709±2835 
(kJ·body mass-1) 279±63 280±59 279±56 278±54 
Intake of dietary variables for the different NZBC dosing conditions of 0, 300, 600 and 900 mg∙day-1. 427 
All values were collected from 48-hour food diaries before each experimental visit. Data reported as 428 
mean ± SD from 15 endurance trained male cyclists.  429 
 430 
 431 
 432 
